In cholangiocarcinoma more than 40% of PTPN3 somatic mutations, activation of PTPN3 mutations promotes cancer cell proliferation and migration and is linked to cancer recurrence (130). This evidence concerns the gene PTPN3 and cholangiocarcinoma.